Grace Therapeutics, Inc. Annual Earnings Per Share, Basic in USD/shares from 2021 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Grace Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2021 to 2023.
  • Grace Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.3 USD/shares, a 30.2% increase year-over-year.
  • Grace Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -0.92 USD/shares, a 83% increase year-over-year.
  • Grace Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -1.35 USD/shares, a 76.4% increase from 2022.
  • Grace Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -5.71 USD/shares, a 2015% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$1 +$4.36 +76.4% Apr 1, 2023 Mar 31, 2024 10-K 2024-06-21
2022 -$6 -$5 -2015% Apr 1, 2022 Mar 31, 2023 10-K 2024-06-21
2021 $0 Apr 1, 2021 Mar 31, 2022 10-K 2023-06-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.